Press Releases| 2015 | 2014
The August 2016 issue of Seattle Met magazine features 65 Seattle Cancer Care Alliance (SCCA) oncologists and specialists as Top Doctors. Physicians from SCCA’s three partner organizations—Fred Hutchinson Cancer Research Center, Seattle Children’s, and UW Medicine—appear prominently throughout the list.
Seattle Cancer Care Alliance (SCCA) nurse and lymphoma survivor Christen Heye, ARNP was named “Woman of the Year” by The Leukemia & Lymphoma Society’s (LLS) Washington/Alaska Chapter. Christen was recognized for being the top female fundraising candidate in the annual Man & Woman of the Year (MWOY) fundraising campaign.
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine. Though infrequent in the general population, inherited mutations in specific types of DNA repair genes, such as BRCA1 and BRCA2, are known to predispose to prostate cancer. However, the rate of such mutations in men with metastatic prostate cancer previously was unknown.
Seattle Cancer Care Alliance (SCCA) nurses and administrators gathered Friday, May 13, 2016, to celebrate local nursing students’ passion to pursue oncology nursing. Called the “Future of Oncology Nursing Scholarship,” this second annual scholarship program awarded three students each with a $3,000 scholarship to put toward their senior year of nursing school.
Today’s issue of The Journal of the American Medical Association (JAMA) features an editorial by two Seattle Cancer Care Alliance (SCCA) medical oncologists who specialize in melanoma: Dr. Shailender Bhatia and Dr. John Thompson. Their editorial addresses the state of immunotherapy drugs, specifically PD-1 blockade, in the treatment of melanoma. Both physicians have been on the front lines of immunotherapy research, including leading early trials of pembrolizumab, the drug used to treat President Jimmy Carter’s melanoma.
Seattle Cancer Care Alliance (SCCA) has been recognized as a “Leader in LGBT Healthcare Equality” by the Human Rights Campaign (HRC) Foundation, the educational arm of the country’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organization. The honor is awarded to healthcare facilities that meet the HRC’s four core LGBT-inclusive benchmarks evaluating organizational policies and practices related to LGBT patients, families and employees.
Seattle Cancer Care Alliance (SCCA) has been named one of “150 Great Places to Work in Healthcare” by Becker’s Healthcare. This is the first time SCCA has been named to the list, which has been published every year since 2011.
Following the success of its recent brand relaunch, Seattle Cancer Care Alliance (SCCA) will kick off its 2016 advertising campaign with a television commercial debuting during the local broadcast of the Super Bowl on Sunday, Feb. 7, on CBS affiliate KIRO-TV.
SEATTLE – (Feb. 3, 2016) – World Cancer Day—Thursday, Feb. 4, 2016—is the web launch of a new global campaign to reduce disparities in breast cancer outcomes for 2.5 million women by 2025. Called Breast Cancer Initiative 2.5 (BCI2.5), the campaign is spearheaded by two internationally renowned breast cancer physicians based in Seattle, Washington: Julie R. Gralow, M.D. and Benjamin O. Anderson, M.D. Both physicians are part of Seattle Cancer Care Alliance and its partners, Fred Hutchinson Cancer Research Center and UW Medicine. To kick-off the campaign on World Cancer Day, BCI2.5 is launching its website, www.bci25.org, which will serve as a platform and resource for policy makers, clinicians and health advocates from across the world.
The February 2016 issue of Seattle Magazine features 33 Seattle Cancer Care Alliance (SCCA) oncologists and specialists as Top Doctors. Physicians from SCCA’s three world-class partner organizations—Fred Hutchinson Cancer Research Center, Seattle Children’s and UW Medicine—appear prominently throughout the list.
Seattle Cancer Care Alliance (SCCA) has hired board-certified, medical oncologist Eric Dean, M.D., who will be based at the SCCA community site EvergreenHealth in Kirkland. He is also a newly appointed faculty member of the University of Washington School of Medicine.
Seattle Cancer Care Alliance researcher and oncologist, Ajay Gopal, M.D., has received one of five national research grants awarded by the National Comprehensive Cancer Network® (NCCN®) to evaluate and define the pre-clinical and clinical effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular and prostate cancers. Dr. Gopal’s study focuses on “Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Phase II Trial of Enzalutamide.”
| 2015 | 2014